Evidence-based policy solutions to prevent eating disorders: Do disclaimer labels on fashion advertisements mitigate negative impact on adult women?

Body Image

Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA 02115, United States; Division of Adolescent and Young Adult Medicine, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115, United States.

Published: December 2022

Exposure to media images portraying the thin ideal is associated with increased body dissatisfaction and disordered eating in women. Organizations and policymakers globally have proposed polices requiring warning or disclaimer labels on altered images. Research examining efficacy of disclaimer labels is growing but has largely overlooked adult women. This study extends current research by exploring novel disclaimer labels in a sample of adult women. Women (N = 872) recruited via Amazon's MTurk were randomly assigned to view 20 fashion advertisements with one of five labels: 1) no label; 2) general-digital-alteration label; 3) health-warning label; 4) specific-weight label; or 5) facial features/cosmetic label. Results revealed a significant increase in body dissatisfaction after advertisement exposure, irrespective of label group. Women who viewed advertisements with labels and recalled the labels reported lower body satisfaction and intention to purchase products compared to those who viewed advertisements with no label. Age appears to play an important role in how disclaimer labels affect women. Younger women of color appear to be more negatively impacted by the facial features/cosmetic label than older women of color. Findings are consistent with previous studies indicating no protective effect of disclaimer labels suggesting the need for more effective preventive strategies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bodyim.2022.08.010DOI Listing

Publication Analysis

Top Keywords

disclaimer labels
24
labels
9
fashion advertisements
8
body dissatisfaction
8
women
8
adult women
8
advertisements labels
8
label
8
facial features/cosmetic
8
features/cosmetic label
8

Similar Publications

The Paediatric Use Marketing Authorisation (PUMA) was introduced in the European Union to incentivise the development of off-patent medicines in children. However, there is limited data on the accessibility of PUMA products at the healthcare provider level. This study aimed to identify factors affecting real-world accessibility to PUMA products in the United Kingdom (UK).

View Article and Find Full Text PDF

A descriptive summary of the WHO availability assessments of medical abortion medicines in eight African countries.

Reprod Health

December 2024

UNDP‑UNFPA‑UNICEF‑WHO‑World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Sexual and Reproductive Health and Research, World Health Organization, 20 Avenue Appia, 1211, Geneva, Switzerland.

Background: The use of medical abortion using either a combination of mifepristone and misoprostol, or misoprostol alone has contributed to increased safety and decreased mortality and morbidity. The availability of quality medical abortion medicines is an essential component in the provision of quality abortion care. Understanding the factors that influence the availability of medical abortion medicines is important to help in-country policymakers, program planners, and providers improve availability and use of medical abortion.

View Article and Find Full Text PDF

Setting: Alcohol is a major cause of health and social costs and harms in Canada. While research and awareness of harms caused by alcohol are on the rise, few transdisciplinary platforms exist that are committed to facilitating bold alcohol policy change to reduce health inequities and improve lives.

Intervention: In response to feedback heard during engagement for the Canadian Alcohol Policy Evaluation project, an alcohol policy-focused community of practice (CoP) was launched in January 2022.

View Article and Find Full Text PDF

Machine learning-assisted literature screening for a medication-use process-related systematic review.

Am J Health Syst Pharm

November 2024

University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, NC, and University of North Carolina Medical Center, Chapel Hill, NC, USA.

Disclaimer: In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!